3652 results for «453»
3652 results
PCI in challenging coronary anatomies
15 May 2024 – From EuroPCR 2024
This session explores various complex PCI cases, providing insights and solutions for navigating challenging coronary anatomies. The discussions cover techniques for crossing difficult paths, the role of PCI as a backup for CABG, and the use of specialized tools like balloons and rotablation when standard approaches...
Challenging situations to access the aortic valve - Part 2
15 May 2024 – From EuroPCR 2024
This session features a series of selected EuroPCR 2024 Clinical Case submissions, showcasing various challenging scenarios encountered during transcatheter aortic valve interventions. Experts will present and discuss cases involving transbrachial TAVI, TAVI on a porcelain aorta, transcaval access, and other complex access approaches, providing valuable insights...
Different procedural techniques for the treatment of heavily calcified coronary lesions
15 May 2024 – From EuroPCR 2024
This session features selected EuroPCR 2024 Clinical Case submissions focused on the management of heavily calcified coronary lesions. Experts will present and discuss various techniques, including the use of artificial intelligence-generated coronary CT angiography for PCI guidance, advanced calcium mapping with coronary CT, orbital atherectomy, and...
Complex PCI in NSTEMI - Part 1
15 May 2024 – From EuroPCR 2024
This session features selected EuroPCR 2024 Clinical Case submissions focused on complex percutaneous coronary interventions (PCI) in patients with non-ST-elevation myocardial infarction (NSTEMI). Experts will present and discuss challenging cases, including scenarios involving bleeding risks, wandering coronary stents, and the use of intravascular ultrasound (IVUS) guidance...
Drug coated balloon PCI in complex scenarios
16 May 2024 – From EuroPCR 2024
This session comprises selected EuroPCR 2024 Clinical Case submissions focused on the use of drug-coated balloons (DCB) in complex PCI scenarios. It covers various case presentations and discussions, including the use of DCB in left main PCI, 2-year angiographic follow-up after left anterior descending artery PCI...
Comparative insights into QFR, FFR, and angiography
16 May 2024 – From EuroPCR 2024
This session, comprising selected EuroPCR 2024 Abstract submissions, focuses on various aspects of assessing and managing multivessel coronary artery disease. It includes presentations and discussions on the use of quantitative flow ratio (QFR) for assessing non-culprit lesions in acute myocardial infarction, functional assessment of surgical revascularization,...
The challenge with ostial CTO lesions
16 May 2024 – From EuroPCR 2024
This session comprises selected EuroPCR 2024 Clinical Case submissions focused on the challenges in treating ostial chronic total occlusion (CTO) lesions. It covers various case presentations and discussions, including the use of specialized techniques and devices to tackle calcified and stumpless ostial right coronary artery CTOs,...
When imaging guides PCI complications management
15 May 2024 – From EuroPCR 2024
This session features selected EuroPCR 2024 Clinical Case submissions highlighting the role of imaging in managing complications during percutaneous coronary interventions (PCI). Experts will present and discuss cases involving recurrent acute myocardial infarction, stent crumpling, and other unexpected complications, demonstrating how the use of various imaging...
SEISMIC-HF I - Exploring non-invasive methods for monitoring intracardiac filling pressures
16 Nov 2024
Luis Ortega provides his take on the SEISMIC-HF I study presented by Liviu Klein at AHA 2024, in Chicago.
Author
OPTIMUM: Outcomes of Percutaneous RevascularizaTIon for Management of SUrgically Ineligible Patients with Multivessel or Left Main Coronary Artery Disease
04 Nov 2021
Mirvat Alasnag reviews the OPTIMUM trial, presented by David E. Kandzari, which reports outcomes in a subset of patients who are increasingly seen in modern day catheterization laboratories. It is noteworthy that 1 in 5 patients with left main or multivessel disease are considered surgically ineligible.
Author
Transcatheter aortic valve replacement for asymptomatic severe aortic stenosis: Results of the EARLY TAVR trial
29 Oct 2024
Luigi Biasco provides his take on the results of the EARLY TAVR trial, presented by Philippe Genereux at TCT 2024 in Washington.
Author
New insights from the early and delayed aortic valve replacement implant patients: a sub-analysis of the Early TAVR trial
29 Mar 2025
Luigi Biasco provides his take on a sub-analysis of the Early TAVR trial about the early and delayed aortic valve replacement implant patients presented by Philippe Genereux at ACC.25 in Chicago.
Author
